Numinus fills several key roles including a new Director of Mergers and Acquisitions and a new Chief Communications Officer.
COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021
Compass Pathways highlights for Q1 include two new patents and reports its Phase IIb clinical trial is on track.
The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury
Wesana inks a multi-year research agreement with the World Boxing Council on psychedelics therapy for Traumatic Brain Injury (TBI).
Media Coverage Of Psychedelic Drugs Soars
For a solid month, there has been an explosion in coverage of the psychedelic drug industry by the mainstream media.
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application
Optimi Health and Numinus Wellness announce a new milestone in their partnership to develop an all-natural psilocybin extract.
Are Millennials Missing An Opportunity With Psychedelic Stocks?
Psychedelic drug stocks are a very progressive investing option for investors seeking high-growth opportunities. So why aren't more Millennials jumping on the bandwagon?
Wesana Health Commences Trading on the CSE
Wesana Health commences trading on the CSE, symbol "WESA".
Psychedelic Stocks Slumber As Investors Sleep Through News
Lots of company news. Lots of industry news. Lots of new capital. But no investors. At the moment, they're busy GAMBLING.
Field Trip Health Ltd. Announces DTC Eligibility
Field Trip is now eligible for clearing and settlement through the DTC, boosting liquidity in the stock.
Red Light Holland Receives Patent Pending Status For 'Find Your Dose' Customization of Microdosing Kits Based on Biometric and Movement Data
Red Light Holland granted patent pending status for its 'Find Your Dose' microdosing kit.
Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021
UK-based Small Pharma Inc will commence trading on the TSX Venture Exchange (via RTO) on May 6, 2021, under the symbol "DMT".
Mydecine Announces Partnership with LeadGen Labs
Mydecine announces a new partnership with LeadGen Labs, aimed at improving its drug synthesis operations.
